Health

Results: 781-792 of 8672

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026

GlobeNewswire associated0

Breakthrough Shown to Cut Dementia Risk, Now Found to Help Repair Brain Injuries

Alkermes plc Announces CEO Succession Plan

Haypp releases new guidance on proportionate regulation of nicotine pouches, helping the UK towards a smoke-free future

LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance

PR Newswire associated0

SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America

PR Newswire associated0

Polaroid Therapeutics (PTx) Receives CE Mark for POLTX_Fiber™: the first application of APT™ to launch a new standard in wound care

ZINZINO AB (PUBL.): YEAR-END REPORT 2025

Ascensia Diabetes Care Appoints Peter Bodlund as President and Chief Executive Officer

Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics

Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis